1. Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
2. Seoul National University Hospital, Seoul, Republic of Korea;
3. Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea;
4. Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;
5. Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
6. Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea;
7. National Taiwan University Hospital, Taipei, Taiwan;
8. Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea;
9. Olivia Newton-John Cancer Research Institute, Heidelberg, Australia;
10. Chris O'Brien Lifehouse, Sydney, Australia;
11. David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA;
12. National Cheng Kung University (NCKU) Hospital, Tainan, Taiwan;
13. Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA;
14. AstraZeneca, Melbourne, United Kingdom;
15. Innovation Center China, Innovative Medicines and Early Development, AstraZeneca, Shanghai, China;